Collegium Pharmaceutical Inc (COLL)
33.67
-0.31
(-0.91%)
USD |
NASDAQ |
May 16, 16:00
33.65
-0.02
(-0.06%)
After-Hours: 20:00
Collegium Pharmaceutical Cash and Short Term Investments (Quarterly): 318.05M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 318.05M |
December 31, 2023 | 310.55M |
September 30, 2023 | 304.56M |
June 30, 2023 | 325.47M |
March 31, 2023 | 269.48M |
December 31, 2022 | 173.69M |
September 30, 2022 | 134.13M |
June 30, 2022 | 122.72M |
March 31, 2022 | 106.70M |
December 31, 2021 | 186.43M |
September 30, 2021 | 193.24M |
June 30, 2021 | 202.77M |
March 31, 2021 | 182.79M |
December 31, 2020 | 174.12M |
September 30, 2020 | 165.42M |
June 30, 2020 | 145.68M |
March 31, 2020 | 116.18M |
December 31, 2019 | 170.02M |
September 30, 2019 | 153.84M |
Date | Value |
---|---|
June 30, 2019 | 148.71M |
March 31, 2019 | 134.91M |
December 31, 2018 | 146.63M |
September 30, 2018 | 139.79M |
June 30, 2018 | 133.75M |
March 31, 2018 | 128.25M |
December 31, 2017 | 118.70M |
September 30, 2017 | 107.61M |
June 30, 2017 | 111.21M |
March 31, 2017 | 129.56M |
December 31, 2016 | 153.22M |
September 30, 2016 | 91.03M |
June 30, 2016 | 110.75M |
March 31, 2016 | 134.73M |
December 31, 2015 | 95.70M |
September 30, 2015 | 105.46M |
June 30, 2015 | 112.41M |
March 31, 2015 | 44.99M |
December 31, 2014 | 1.634M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
106.70M
Minimum
Mar 2022
325.47M
Maximum
Jun 2023
195.23M
Average
173.90M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Catalyst Pharmaceuticals Inc | 310.41M |
Supernus Pharmaceuticals Inc | 297.74M |
AnaptysBio Inc | 354.66M |
Recursion Pharmaceuticals Inc | 296.33M |
Nuvalent Inc | 691.84M |